Reka, G. et al. 2021. Casirivimab and imdevimab as investigational monoclonal antibodies for COVID-19 patients – review of the literature. Current Issues in Pharmacy and Medical Sciences. 34, 3 (Oct. 2021), 138–141. DOI:https://doi.org/10.2478/cipms-2021-0030.